JPRN-UMIN000021735已完成未知
Carbohydrate antigen19-9 (CA19-9) levels in patients with autosomal dominant polycystic kidney disease (ADPKD) - CA19-9 levels in ADPKD
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18years-old 至 90years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •under 18 y.o. and more than 90 y.o.
研究者
相似试验
尚未招募
Unknown
Correlation of CA19-9 blood marker and ability to cure pancreatic cancer with surgeryCTRI/2024/07/071305Dr Shrey Khanna
尚未招募
不适用
Clinical Value of CA 19-9 with Reference to the Lewis Blood Group Status for Prediction of Benign and Malignant Obstructive JaundiceObstructive jaundiceCA 19NjLewis blood groupTCTR20160927002The Thailand Research Fund (TRF)129
Unknown
不适用
Carbohydrate Antigen 19-9 in Colorectal CancerColorectal CancerNCT04999072Seoul National University Hospital4,972
已完成
2 期
Perioperative MVT-5873, a Fully Human Monoclonal Antibody Against a CA 19-9 Epitope, for Operable CA 19-9 Producing Pancreatic Cancers, Cholangiocarcinomas, and Metastatic Colorectal CancersMetastatic Colon CarcinomaLiver MetastasisPancreatic CancerColon CancerCholangiocarcinomaNCT03801915National Cancer Institute (NCI)10
已完成
不适用
To find a tumor marker in colorectal cancer where the conventional marker fails and its impact on short term patient survivalCTRI/2021/09/036543Medical College Kolkata41